Our Leadership
To deliver on the promise of our novel therapeutic approaches, we have assembled an experienced leadership team with deep expertise in each of our core disciplines of immunotherapy research, genomics and bioinformatics, clinical and regulatory development, and biomanufacturing.
Andrew Allen, M.D., Ph.D.
Co-founder, President and Chief Executive Officer
Celia Economides
Executive Vice President and Chief Financial Officer
Matthew Hawryluk, Ph.D.
Executive Vice President and Chief Business Officer
Erin E. Jones, M.S.
Executive Vice President and Chief Operating Officer
Karin Jooss, Ph.D.
Executive Vice President and Head of Research & Development
Stacy Proctor
Executive Vice President and Chief People Officer
Vijay Yabannavar, Ph.D.
Executive Vice President and Chief Technical Development Officer